TNF Receptor Signaling Contributes to Chemokine Secretion, Inflammation, and Respiratory Deficits during Pneumocystis Pneumonia

Journal of Immunology

Volumn 172, Issue 4, 2004, Pages 2511-2521

  Wright, Terry W ^a   Pryhuber, Gloria S ^a   Chess, Patricia R ^a   Wang, Zhengdong ^a   Notter, Robert H ^a   Gigliotti, Francis ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CHEMOKINE; CYTOKINE INDUCED NEUTROPHIL CHEMOATTRACTANT; LUNG SURFACTANT; MACROPHAGE INFLAMMATORY PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREATHING RATE; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; INFLAMMATION; INFLAMMATORY CELL; LUNG ALVEOLITIS; LUNG COMPLIANCE; LUNG FUNCTION; LUNG INJURY; LYMPHOCYTE DEPLETION; MOUSE; NONHUMAN; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0842300353     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.4.2511     Document Type: Article

References (76)

1. Rosen, M. J. 1992. Pulmonary complications of HIV infection. Mt. Sinai J. Med. 59:263.
2. Walzer, P. D., D. P. Perl, D. J. Krogstad, P. G. Rawson, and M. G. Schultz, 1974. Pneumocystis carinii pneumonia in the United States: epidemiologic, diagnostic and clinical features. Ann. Intern. Med. 80:83.
3. Koval, C. E., F. Gigliotti, D. Nevins, and L. M. Demeter. 2002. Immune reconstitution syndrome after successful treatment of Pneumocystis carinii pneumonia in a man with human immunodeficiency virus type 1 infection. Clin. Infect. Dis. 35:491.
4. Barry, S. M., M. C. Lipman, A. R. Deery, M. A. Johnson, and G. Janossy. 2002. Immune reconstitution pneumonitis following Pneumocystis carinii pneumonia in HIV-infected subjects. HIV. Med. 3:207.
5. Smith, R. L., W. M. el-Sadr, and M. L. Lewis, 1988. Correlation of bronchoalveolar lavage cell populations with clinical severity of Pneumocystis carinii pneumonia. Chest 93:60.
6. Limper, A. H., K. P. Offord, T. F. Smith, and W. J. Martin II. 1989. Pneumocystis carinii pneumonia: differences in lung parasite number and inflammation in patients with and without AIDS. Am. Rev. Respir. Dis. 140:1204.
7. Mason, G. R., C. H. Hashimoto, P. S. Dickman, L. F. Foutty, and C. J. Cobb. 1989. Prognostic implications of bronchoalveolar lavage neutrophilia in patients with Pneumocystis carinii pneumonia and AIDS. Am. Rev. Respir. Dis. 139:1336.
8. Benfield, T. L., J. Vestbo, J. Junge, T. L. Nielsen, A. B. Jensen, and J. D. Lundgren. 1995. Prognostic value of interleukin-8 in AIDS-associated Pneumocystis carinii pneumonia. Am. J. Respir. Crit. Care Med. 151:1058.
9. Venet, A., F. Clavel, D. Israel-Biet, C. Rouzioux, G. Dennewald. M. Stern, D. Vittecoq, B. Regnier, E. Cayrol, and J. Chretien. 1985. Lung in acquired immune deficiency syndrome: infectious and immunological status assessed by bronchoalveolar lavage. Bull. Eur. Physiopathol. Respir. 21:535.
10. Jensen, B. N., I. M. Lisse, J. Gerstoft, S. Borgeskov, and P. Skinhoj. 1991. Cellular profiles in bronchoalveolar lavage fluid of HIV-infected patients with pulmonary symptoms: relation to diagnosis and prognosis. AIDS 5:527.
11. Kagi, M. K., W. Fierz, P. J. Grob, and E. W. Russi. 1993. High proportion of γ-δ T cell receptor positive T cells in bronchoalveolar lavage and peripheral blood of HIV-infected patients with Pneumocystis carinii pneumonias. Respiration 60:170.
12. + lymphocytes in host defense against Pneumocystis carinii in mice. J. Lab Clin. Med. 128:477.
13. Beck, J. M., M. L. Warnock, J. L. Curtis, M. J. Sniezek, S. M. Arraj-Peffer, H. B. Kaltreider, and J. E. Shellito. 1991. Inflammatory responses to Pneumocystis carinii in mice selectively depleted of helper T lymphocytes. Am. J. Respir. Cell Mol. Biol. 5:186.
14. Walzer, P. D., M. LaBine, T. J. Redington, and M. T. Cushion. 1984. Lymphocyte changes during chronic administration of and withdrawal from corticosteroids: relation to Pneumocystis carinii pneumonia. J. Immunol. 133:2502.
15. Croix, D. A., K. Board, S. Capuano, M. Murphey-Corb, C. G. Haidaris, J. L. Flynn, T. Reinhart, and K. A. Norris. 2002. Alterations in T lymphocyte profiles of bronchoalveolar lavage fluid from SIV- and Pneumocystis carinii-coinfected rhesus macaques. AIDS Res. Hum. Retroviruses 18:391.
16. + T cells. J. Immumol. 162:2890.
17. Wright, T. W., F. Gigliotti, J. N. Finkelstein, J. T. McBride, C. L. An, and A. G. Harmsen. 1999. Immune-mediated inflammation directly impairs pulmonary function contributing to the pathogenesis of Pneumocystis pneumonia. J. Clin. Invest. 104:1307.
18. Wright, T. W., R. H. Notter, Z. Wang, A. G. Harmsen, and F. Gigliotti. 2001. Pulmonary inflammation disrupts surfactant function during Pneumocystis carinii pneumonia. Infect. Immun. 2001, 69:758.
19. Bazzoni, F., and B. Beutler. 1996. The tumor necrosis factor ligand and receptor families. N. Engl. J. Med. 334:1717.
20. Mackay, F., P. R. Bourdon, D. A. Griffiths, P. Lawton, M. Zafari, I. D. Sizing, K. Miatkowski, A. Ngam-ek, C. D. Benjamin, C. Hession, et al. 1997. Cytotoxic activities of recombinant soluble murine lymphotoxin-α and lymphotoxin-αβ complexes. J. Immunol. 159:3299.
21. Kolls, J. K., J. M. Beck, S. Nelson, W. R. Summer, and J. Shellito. 1993. Alveolar macrophage release of tumor necrosis factor during Pneumocystis carinii pneumonia. Am. J. Respir. Cell Mol. Biol. 8:370.
22. Vassallo, R., J. E. Standing, and A. H. Limper. 2000. Isolated Pneumocystis carinii cell wall glucan provokes lower respiratory tract inflammatory responses. J. Immunol. 164:3755.
23. Hoffman, O. A., J. E. Standing, and A. H. Limper. 1993. Pneumocystis carinii stimulates tumor necrosis factor-α release from alveolar macrophages through a β-glucan-mediated mechanism. J. Immunol. 150:3932.
24. Kolls, J. K., L. Dinghua, C. Vazquez, G. Odom, W. R. Summer, S. Nelson, and J. Shellito. 1997. Exacerbation of murine Pneumocystis carinii infection by adenoviral-mediated gene transfer of a TNF inhibitor. Am. J. Respir. Cell Mol. Biol. 16:112.
25. Chen, W., E. A. Havell, and A. G. Harmsen. 1992. Importance of endogenous tumor necrosis factor a and γ interferon in host resistance against Pneumocystis carinii infection. Infect. Immun. 60:1279.
26. Sukura, A., Y. T. Konttinen, R. Sepper, and L. A. Lindberg. 1995. Recovery from Pneumocystis carinii pneumonia in dexamethasone-treated Wistar rats. Eur. Respir. J. 8:701.
27. Downing, J. F., D. L. Kachel, R. Pasula, and W. J. Martin. 1999. γ Interferon stimulates rat alveolar macrophages to kill Pneumocystis carinii by L-arginine- and tumor necrosis factor-dependent mechanisms. Infect. Immun. 67:1347.
28. Rudmann, D. G., A. M. Preston, M. W. Moore, and J. M. Beck. 1998. Susceptibility to Pneumocystis carinii in mice is dependent on simultaneous deletion of IFN-γ and type 1 and 2 TNF receptor genes. J. Immunol. 161:360.
29. Wright, T. W., C. J. Johnston, A. G. Harmsen, and J. N. Finkelstein. 1999. Chemokine gene expression during Pneumocystis carinii-driven pulmonary inflammation. Infect. Immun. 67:3452.
30. Czermak, B. J., V. Sarma, N. M. Bless, H. Schmal, H. P. Friedl, and P. A. Ward. 1999. In vitro and in vivo dependency of chemokine generation on C5a and TNF-α. J. Immunol. 162:2321.
31. Tessier, P. A., P. H. Naccache, I. Clark-Lewis, R. P. Gladue, K. S. Neote, and S. R. McColl. 1997. Chemokine networks in vivo: involvement of C-X-C and C-C chemokines in neutrophil extravasation in vivo in response to TNF-α. J. Immumol. 159:3595.
32. + T cell recognition. J. Clin. Invest. 106:R49.
33. Sedgwick, J. D., D. S. Riminton, J. G. Cyster, and H. Korner. 2000. Tumor necrosis factor: a master-regulator of leukocyte movement. Immunol. Today 21:110.
34. Adams, D. H., and A. R. Lloyd. 1997. Chemokines: leucocyte recruitment and activation cytokines. Lancet 349:490.
35. Mahalingam, S., and G. Karupiah. 1999. Chemokines and chemokine receptors in infectious diseases. Immunol. Cell Biol. 77:469.
36. Benfield, T. L., B. Lundgren, J. H. Shelhamer, and J. D. Lundgren. 1999. Pneumocystis carinii major surface glycoprotein induces interleukin-8 and monocyte chemoattractant protein-1 release from a human alveolar epithelial cell line. Eur. J. Clin. Invest. 29:717.
37. Hahn, P. Y., S. E. Evans, T. J. Kottom, J. E. Standing, R. E. Pagano, and A. H. Limper. 2003. Pneumocystis carinii cell wall β-glucan induces release of macrophage inflammatory protein-2 from alveolar epithelial cells via a lactosyl-ceramide-mediated mechanism. J. Biol. Chem. 278:2043.
38. + T cell-mediated injury in vivo progresses in the absence of effector T cells. J. Exp. Med. 194:1835.
39. + cells in resistance to Pneumocystis carinii pneumonia in mice. J. Exp. Med. 172:937.
40. Peschon, J. J., D. S. Torrance, K. L. Stocking, M. B. Glaccum, C. Otten, C. R. Willis, K. Charrier, P. J. Morrissey, C. B. Ware, and K. M. Mohler. 1998. TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation. J. Immunol. 160:943.
41. + T cell-independent vaccination against Pneumocystis carinii in mice. J. Clin. Invest. 108:1469.
42. Palladino, S., I. Kay, R. Fonte, and J. Flexman. 2001. Use of real-time PCR and the LightCycler system for the rapid detection of Pneumocystis carinii in respiratory specimens. Diagn. Microbiol. Infect. Dis. 39:233.
43. Larsen, H. H., H. Masur, J. A. Kovacs, V. J. Gill, V. A. Silcott, P. Kogulan, J. Maenza, M. Smith, D. R. Lucey. and S. H. Fischer. 2002. Development and evaluation of a quantitative, touch-down, real-time PCR assay for diagnosing Pneumocystis carinii pneumonia. J. Clin. Microbiol. 40:490.
44. Lee, L. H., F. Gigliotti, T. W. Wright, P. J. Simpson-Haidaris, G. A. Weinberg, and C. G. Haidaris. 2000. Molecular characterization of KEX1, a kexin-like protease in mouse Pneumocystis carinii. Gene 242:141.
45. Wright, T. W., C. J. Johnston, A. G. Harmsen, and J. N. Finkelstein. 1997. Analysis of cytokine mRNA profiles in the lungs of Pneumocystis carinii-infected mice. Am. J. Respir. Cell Mol. Biol. 17:491.
46. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265.
47. Ames, B. N. 1966. Assay of inorganic phosphate, total phosphate and phosphatases. Methods Enzymol. 8:115.
48. Enhorning, G. 1977. Pulsating bubble technique for evaluation of pulmonary surfactant. J. Appl. Physiol. 43:198.
49. Hall, S. B., M. S. Bermel, K. T. Ko, H. J. Palmer, G. Enhorning, and R. H. Notter. 1993. Approximations in the measurement of surface tension on the oscillating bubble surfactometer. J. Appl. Physiol. 75:467.
50. Lowin, B., M. Hahne, C. Mattmann. and J. Tschopp. 1994. Cytolytic T-cell cytotoxicity is mediated through perform and Fas lytic pathways. Nature 370:650.
51. Fine, A., N. L. Anderson, T. L. Rothstein, M. C. Williams, and B. R. Gochuico. 1997. Fas expression in pulmonary alveolar type II cells. Am. J. Physiol. 273:L64.
52. Kinkhabwala, M., P. Sehajpal, E. Skolnik, D. Smith, V. K. Sharma, H. Vlassara, A. Cerami, and M. Suthanthiran. 1990. A novel addition to the T cell repertory: cell surface expression of tumor necrosis factor/cachectin by activated normal human T cells. J. Exp. Med. 171:941.
53. + T-cell-mediated cytotoxicity of alveolar epithelial cells is preferentially mediated by tumor necrosis factor-α: relative insensitivity to Fas ligand. Am. J. Respir. Cell Mol. Biol. 20:849.
54. Mosmann, T. R., L. Li, and S. Sad. 1997. Functions of CD8 T-cell subsets secreting different cytokine patterns. Semin. Immunol. 9:87.
55. + T cells. Science 270:1811.
56. Lloyd, A. R., J. J. Oppenheim, D. J. Kelvin, and D. D. Taub. 1996. Chemokines regulate T cell adherence to recombinant adhesion molecules and extracellular matrix proteins. J. Immumol. 156:932.
57. + T lymphocytes. FASEB J. 8:1055.
58. del, P. M., P. Sanchez-Mateos, M. Nieto, and F. Sanchez-Madrid. 1995. Chemokines regulate cellular polarization and adhesion receptor redistribution during lymphocyte interaction with endothelium and extracellular matrix: involvement of cAMP signaling pathway. J. Cell Biol. 131:495.
59. Lima, M. F., Y. Zhang, and F. Villalta. 1997. Beta-chemokines that inhibit HIV-1 infection of human macrophages stimulate uptake and promote destruction of Trypanosoma cruzi by human macrophages. Cell. Mol. Biol. 43:1067.
60. Taub, D. D., J. R. Ortaldo, S. M. Turcovski-Corrales, M. L. Key, D. L. Longo, and W. J. Murphy. 1996. β chemokines costimulate lymphocyte cytolysis, proliferation, and lymphokine production. J. Leukocyte Biol. 59:81.
61. Taub, D. D., S. M. Turcovski-Corrales, M. L. Key, D. L. Longo, and W. J. Murphy. 1996. Chemokines and T lymphocyte activation. I. β chemokines costimulate human T lymphocyte activation in vitro. J. Immunol. 156:2095.
62. Kim, J. J., L. K. Nottingham, J. I. Sin, A. Tsai. L. Morrison, J. Oh, K. Dang, Y. Hu, K. Kazahaya, M. Bennett, et al. 1998. CD8 positive T cells influence antigen-specific immune responses through the expression of chemokines. J. Clin. Invest. 102:1112.
63. Jiang, Y., D. I. Beller, G. Frendl, and D. T. Graves. 1992. Monocyte chemoattractant protein-1 regulates adhesion molecule expression and cytokine production in human monocytes. J. Immumol. 148:2423.
64. Vaddi, K., and R. C. Newton. 1994. Regulation of monocyte integrin expression by β-family chemokines. J. Immumol. 153:4721.
65. Damas, P., A. Reuter, P. Gysen, J. Demonty, M. Lamy, and P. Franchimont. 1989. Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans. Crit. Care Med. 17:975.
66. Parrillo, J. E., M. M. Parker, C. Natanson, A. F. Suffredini, R. L. Danner, R. E. Cunnion, and F. P. Ognibene. 1990. Septic shock in humans: advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann. Intern. Med. 113:227.
67. Kollias, G., E. Douni, G. Kassiotis, and D. Kontoyiannis. 1999. On the role of tumor necrosis factor and receptors in models of multiorgan failure, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease. Immunol. Rev. 169:175.
68. Horn, T. L., T. D. O'Brien, L. B. Schook, and M. S. Rutherford. 2000. Acute hepatotoxicant exposure induces TNFR-mediated hepatic injury and cytokinea/poptotic gene expression. Toxicol. Sci. 54:262.
69. Mulligan, M. S., A. A. Vaporciyan, M. Miyasaka, T. Tamatani, and P. A. Ward. 1993. Tumor necrosis factor a regulates in vivo intrapulmonary expression of ICAM-1. Am. J. Pathol. 142:1739.
70. Neumann, B., T. Machleidt, A. Lifka, K. Pfeffer, D. Vestweber, T. W. Mak, B. Holzmann, and M. Kronke. 1996. Crucial role of 55-kilodalton TNF receptor in TNF-induced adhesion molecule expression and leukocyte organ infiltration. J. Immunol. 156:1587.
71. Pfeffer, K. 2003. Biological functions of tumor necrosis factor cytokines and their receptors. Cytokine Growth Factor Rev. 14:185.
72. Vieira, L. Q., M. Goldschmidt, M. Nashleanas, K. Pfeffer, T. Mak, and P. Scott. 1996. Mice lacking the TNF receptor p55 fail to resolve lesions caused by infection with Leishmania major, but control parasite replication. J. Immunol. 157:827.
73. Bean, A. G., D. R. Roach, H. Briscoe, M. P. France, H. Korner, J. D. Sedgwick, and W. J. Britton. 1999. Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin, J. Immunol. 162:3504.
74. Maini, R. N., M. J. Elliott, F. M. Brennan, and M. Feldmann. 1995. Beneficial effects of tumour necrosis factor-α (TNF-α) blockade in rheumatoid arthritis (RA). Clin. Exp. Immunol. 101:207.
75. D'Haens, G. 2003. Anti-TNF therapy for Crohn's disease. Curr. Pharm. Des. 9:289.
76. Gottlieb, A. B., and J. D. Bos. 2002. Recombinantly engineered human proteins: transforming the treatment of psoriasis. Clin. Immunol. 105:105.